Metaplastic Breast Carcinoma in Vietnam: Clinicopathological Characteristics and Therapeutic Approaches from a Multicenter Investigation
DOI:
https://doi.org/10.64917/fmcs-008Keywords:
Metaplastic breast carcinoma, Vietnam, clinicopathological characteristics, therapeutic approachesAbstract
This multicenter study investigates the clinicopathological features and treatment strategies for metaplastic breast carcinoma (MBC) in a Vietnamese patient cohort. MBC is a rare and aggressive subtype of breast cancer, often associated with unique histological characteristics and a poorer prognosis compared to more common breast cancer types. This research aims to provide comprehensive data on MBC in Vietnam, a region where specific epidemiological and clinical insights into this malignancy are limited. By analyzing patient demographics, tumor characteristics, treatment modalities, and outcomes from multiple institutions, this study elucidates the distinct profile of MBC in this population, contributing to a better understanding of its management in a non-Western context. The findings highlight the challenges in diagnosis and treatment and offer valuable insights for optimizing therapeutic approaches for Vietnamese patients with MBC.
References
Naghavi M, Kl O, Aali A, et al. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet 2024;403:2100–32.
Alkabban FM, Ferguson T. Breast Cancer. In: StatPearls. Treasure Island (FL); 2024.
Abouharb S, Moulder S. Metaplastic breast cancer: clinical overview and molecular aberrations for potential targeted therapy. Curr Oncol Rep 2015;17:431.
Jenkins S, Kachur ME, Rechache K, et al. Rare breast cancer subtypes. Curr Oncol Rep 2021;23:54.
Thapa B, Arobelidze S, Clark BA, et al. Metaplastic breast cancer: characteristics and survival outcomes. Cureus 2022;14:e28551.
Sinn HP, Kreipe H. A brief overview of the WHO classification of breast tumors, 4th edition, focusing on issues and updates from the 3rd edition. Breast Care (Basel) 2013;8:149–54.
Nelson RA, Guye ML, Luu T, Lai LL. Survival outcomes of metaplastic breast cancer patients: results from a US population-based analysis. Ann Surg Oncol 2015;22:24–31.
Weigelt B, Eberle C, Cowell CF, et al. Metaplastic breast carcinoma: more than a special type. Nat Rev Cancer 2014;14:147–48.
Puskulluoglu M, Swiderska K, Konieczna A, et al. Clinical analysis of metaplastic breast carcinoma with distant metastases: a multi-centre experience. Oncol Lett 2024;27:198.
Sherwani M, Vohra L, Ali D, et al. Clinicopathological features and survival outcomes of metaplastic breast carcinoma – an observational multi-centric study. Breast Cancer (Dove Med Press) 2023;15:237–50.
Stapleton SM, Oseni TO, Bababekov YJ, et al. Race/ethnicity and age distribution of breast cancer diagnosis in the United States. JAMA Surg 2018;153:594–95.
Weigelt B, Ng CK, Shen R, et al. Corrigendum: metastatic breast carcinomas display genomic and transcriptomic heterogeneity. Mod Pathol 2015;28:607.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Dr. Nguyen Thi Lan Anh, Dr. Tran Van Minh
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their articles published in this journal. All articles are licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly cited.